🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Softgel(s) Serving Size
360 Servings
Vitamin Product Type
100% Evidence Coverage

Supplement Facts — Evidence Check

250 mcg (313% DV)
📊 Market median: 99.0mg (52 products) 📚 234 studies (Tier A: 4, B: 113)
RDA 3400mg This product: 0.25mg

Other Ingredients

extra virgin Olive Oil Soft-Gelatin Capsule

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (100% of products) Structure/Function (84% of products) Nutrient (73% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Suggested Use Consume one capsule daily or as recommended by a health care professional.

⚠️ Warnings & Precautions

Warning Unless directed by a physician, vitamin K is not for use with any anticoagulant drugs (Coumadin, Warfarin, Heparin, etc).

If you have ever experienced any blood clotting abnormalities, consult with a health professional before using this or any vitamin K-containing product.

🧪 Formulation Notes

Highest activity vitamin K2

Andrew Lessman's Vitamin K2 MK-7 200 provides a high potency blend of vitamin K in the form of vitamin K-1 (phytonadione) and, most importantly, as vitamin K-2 menaquinone-7 (MK-7) to deliver newly recognized and essential benefits to bone and heart health.

Our Vitamin K2 MK-7 200 is formulated to deliver an unsurpassed source of vitamin K-2 for optimum bone and heart health.

Contains no milk, soy, yeast, corn, wheat, gluten, sodium, salt, sugar, cholesterol, color, preservative, common allergens or manufacturing additives.

Contains no additives of any kind.

Additional Information

This product is most effective as part of a healthy diet and active lifestyle, along with one of Andrew Lessman's multi-vitamin-mineral formulas. For answers to questions about the use of this product, call 800.808.7311.

605934-01U

Promotes bone and heart health

All-Solar manufacturing

Vitamin K's name originates from the role of vitamin K-1 in blood clotting (koagulation in German) but, today, its most important function centers around vitamin K-2 MK-7 and its now recognized role in the utilization of calcium within the body and, as a result, its indispensable role in both bone health, as well as heart and cardiovascular health. These far-reaching benefits to skeletal and cardiovascular health have now been consistently observed and established in the scientific literature.

Plus, for any person consuming calcium and vitamin D, vitamin K-2 MK-7 has been shown to ensure the greatest benefits of those essential nutrients. It is also important to note that the best source of vitamin K-2 is the unusual Japanese food called fermented natto from soybeans, which virtually no Americans consume. Fortunately, our vitamin K2 MK-7 200 makes it easy and economical to obtain all the benefits of vitamin K-2 in a small easy-to-swallow capsule.

Product Details

DSLD Entry Date 2018-07-25
Product Type Vitamin
Form Softgel Capsule
DSLD ID 179071
Data Updated 2026-04-11

Research Evidence

332 Research Sources
59 Avg Quality Score
220 Meta Analysis
56 Systematic Review
30 Rct
16 Clinical Trial
3 Guideline
3 Regulatory Source
1 Narrative Review
1 Other
1 Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014
View all evidence for Vitamin K →

Compare Similar Products

View all Vitamin K products →